Evidence map›Paper›PMID 40100271›Full record

ArticleMicrobial genomics2025

Genomic characterization of

Abel Abera Negash, Ana Ferreira, Daniel Asrat, Abraham Aseffa, Piet Cools, Leen Van Simaey, Mario Vaneechoutte, Stephen D Bentley, Stephanie W Lo

Abstract read
In one paragraph

Article in Microbial genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Abel Abera NegashArmauer Hansen Research Institute (AHRI), Addis Ababa, Ethiopia.
Ana FerreiraParasites and Microbes, Wellcome Sanger Institute, Hinxton, UK.
Daniel AsratDepartment of Microbiology, Immunology and Parasitology, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia.
Abraham AseffaArmauer Hansen Research Institute (AHRI), Addis Ababa, Ethiopia.
Piet CoolsLaboratory Bacteriology Research, Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
Leen Van SimaeyLaboratory Bacteriology Research, Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
Mario VaneechoutteLaboratory Bacteriology Research, Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
Stephen D BentleyParasites and Microbes, Wellcome Sanger Institute, Hinxton, UK.
Stephanie W LoParasites and Microbes, Wellcome Sanger Institute, Hinxton, UK.

Funding

Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carrier StatePneumococcal InfectionsStreptococcus pneumoniaeAdolescentAnti-Bacterial AgentsChildChild, PreschoolDrug Resistance, BacterialEthiopiaFemaleGenome, BacterialHumansInfantMaleMicrobial Sensitivity TestsPneumococcal VaccinesAnti-Bacterial AgentsPneumococcal VaccinesEthiopiaGPSC1GPSC10PCV10serotype 19AStreptococcus pneumoniae

Identifiers

PMID40100271
PMCPMC11986848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.